The Honourable Members of the European Parliament:
Carl Schlyter MEP (Green party- Sweden),
Dorette Corbey MEP (PSE- Netherlands),
Luisa Morgantini MEP (GUE/NGL - Italy),
are pleased to host the launch of a report by Médecins Sans Frontières:
How much does the European Commission pay for tuberculosis R&D?
Médecins Sans Frontières has explored the European Commission's contribution to the funding of R&D for TB and other neglected diseases and analyses why that funding is still grossly insufficient in comparison to the need. Why is this the case? What would the EC's fair share be? How can funding streams be improved so that the money matches the needs? What needs to happen?
12:30-2pm, Wednesday 12th November 2008, European Parliament, Room A5G2
Chair Carl Schlyter, MEP
Opening remarks
Luisa Morgantini, MEP
How much does the European Commission pay for tuberculosis R&D?
Presentation of the Médecins Sans Frontières, Access to Essential Medicines Campaign Report: Dr. Tido von Schoen-Angerer, Director, MSF Access to Essential Medicines Campaign
Spring Gombe, Main author of the report, Consultant to MSF
Respondents:
Prof. Stewart Cole, Head of Laboratories, Ecole Publique Polytechnique Fédérale de Lausanne
Louise Baker, Senior Strategist, Stop TB partnership Discussion
Closing remarks
Dorette Corbey, MEP